Welcome, Guest! - or
Easy to remember!  »  VinNews.com

Princeton, NJ - Drug Company Recalls Generic Lipitor after Glass Particles Found

Published on: November 23, 2012 12:00 PM
By: AP
Change text size Text Size  
Bookmark and Share

Princeton, NJ - Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string of manufacturing deficiencies that once led U.S. regulators to bar imports of the Indian company’s medicines.

Ranbaxy, a subsidiary of Ranbaxy Laboratories Ltd., India’s biggest drugmaker, is operating under increased scrutiny from the U.S. Food and Drug Administration because of quality lapses at multiple Ranbaxy factories over the past several years. The FDA also has alleged the company lied about test results for more than two dozen of its generic drugs several years ago.

On Friday, Ranbaxy posted a notice on its U.S. website, saying it’s recalling 10-, 20- and 40-milligram doses of tablets of atorvastatin calcium. That’s generic Lipitor, the cholesterol fighter that reigned for years as the world’s top-selling drug.

The recall includes 41 lots of the drug, nearly all with 90 pills per bottle, but three lots contain 500 pills per bottle. It’s unclear how many bottles are in each lot, but medicine batches typically contain many thousands of pills. The 80-milligram strength tablets are not affected.

A Ranbaxy spokesman did not immediately respond to messages from The Associated Press seeking further information.

Advertisement:

“Ranbaxy is proactively recalling the drug product lots out of an abundance of caution,” the company said on its website. “This recall is being conducted with the full knowledge of the U.S. FDA.”

The company also filed a two-sentence statement with the Bombay Stock Exchange stating Ranbaxy’s investigation would be completed within two weeks, but that after that temporary disruption to the U.S. supply, the company expected to resume shipments here.

Patients who’ve filled a prescription can contact their pharmacy to determine whether it was made by Ranbaxy or another generic drugmaker and, if it’s from Ranbaxy, whether it came from a recalled lot.

Ranbaxy’s manufacturing deficiencies, dating to 2006, led to a lengthy investigation and sanctions by the FDA. During the probe, federal investigators found Ranbaxy didn’t properly test the shelf life and other safety factors of its drugs and then lied about the results.

In mid-2008, the FDA barred Ranbaxy from shipping into the U.S more than 30 different drugs made at factories in India. Meanwhile, the U.S. Department of Justice demanded Ranbaxy turn over internal documents, alleging the company lied about ingredients and formulations of some medications.

In early 2009, the FDA said it would not consider any new applications from Ranbaxy to sell in the U.S. any products made at the troubled factories.

As FDA discussions with Ranbaxy continued, it appeared Ranbaxy would lose its shot at a revenue windfall when Lipitor’s generic U.S. patent expired last Nov. 30. At the time, Lipitor brought in almost $8 billion a year in U.S. sales.

As often happens when patents first expire, for the first six months only one generic rival could compete with brand-name Lipitor. Ranbaxy had that right, although an authorized generic from Lipitor maker Pfizer Inc. and partner Watson Pharmaceuticals Inc. went on sale on Dec. 1. With competition so limited, the generic prices only declined a bit from brand-name drug’s price of about $115 a month — until several other generics entered the market six months later.

The FDA finally ended the suspense, deciding just before midnight on Nov. 30 to let Ranbaxy sell generic Lipitor made at the company’s Ohm Laboratories factory in central New Jersey. It was unclear Friday whether the recalled Ranbaxy pills were made there or elsewhere.

Meanwhile, Ranbaxy is operating under a settlement with the FDA, called a consent decree, signed on Dec. 20, 2011. It requires Ranbaxy to improve manufacturing procedures, ensure data on its products is accurate and undergo extra oversight and review by an independent third party for five years. Ranbaxy at the time set aside $500 million to cover potential criminal and civil liability stemming from the Justice Department investigation.


More of today's headlines

Dubai, United Arab Emirates - The courtship of Hamas between rivals Iran and Qatar has been one of the Middle East's intriguing subplots of the Arab Spring. The... New York - The jackpot for Powerball's Saturday drawing has climbed to $325 million, the fourth-largest in the game's history. A single winner choosing a cash payout...

 

Total7

Read Comments (7)  —  Post Yours »

1

 Nov 23, 2012 at 02:30 PM monalisa Says:

It's not enough I take generic Lipitor, I now have to worry about glass in the pills? Insane.

2

 Nov 23, 2012 at 02:41 PM monalisa Says:

Yes. Mine is one of the contaminated lots, filled in Duane Reade in Broadway, Manhattan. Better check, folks. THANK YOU, VIN, for posting this, I would never have known because DR sure aren't calling me. In fact, the lady I just spoke to @ DR said I have to bring them back to THAT pharmacy (so I will not be able to take them till Monday night.) And she knew there was a recall, but didn't know why.

WOW!!! VIN, you may be literally lifesavers! :)

3

 Nov 23, 2012 at 04:10 PM Anonymous Says:

So much for generics!

4

 Nov 24, 2012 at 06:50 PM from-here_to-there Says:

I get mine form medco mail order and they were extremely uncooperative on the phone.

5

 Nov 24, 2012 at 08:56 PM Pharmacist Says:

Well you know what this means.
The price is going to go through the roof

6

 Nov 24, 2012 at 09:02 PM Anonymous Says:

Reply to #4  
from-here_to-there Says:

I get mine form medco mail order and they were extremely uncooperative on the phone.

Apparently mail order is not all its cracked up to be
I stopped getting my prescriptions filled by Medco years ago. I use my local pharmacy, the extra cost is minimal( usually just one extra copay) and well worth it. I also have the luxury of consulting with my pharmacist when I want to , instead of some rude ditz that usually passes my call up the chain to someone that promises to call back .

7

 Nov 24, 2012 at 10:50 PM monalisa Says:

Thanks to Obamacare (this is what the insurance co told me), one of my medicines is no longer covered & it's $260 a month. So I get it from Canada & I now pay $30 a month...cheaper than my copay when it WAS covered. Go figure.

8

Sign-in to post a comment

Scroll Up
Advertisements:

Sell your scrap gold and broken jewelry and earn hard cash sell gold today!